Vascular endothelial growth factor receptor 2 (VEGFR-2) functions to promote uterine decidual angiogenesis during early pregnancy in the mouse

Endocrinology

Volumn 150, Issue 8, 2009, Pages 3845-3854

  Douglas, Nataki C ^a   Tang, Hongyan ^a   Gomez, Raul ^a   Pytowski, Bronislaw ^b   Hicklin, Daniel J ^c   Sauer, Christopher M ^a   Kitajewski, Jan ^a   Sauer, Mark V ^a   Zimmermann, Ralf C ^a  

^a Howard Hughes Medical Institute   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROGESTERONE; PROTEIN ANTIBODY; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO DEVELOPMENT; FEMALE; FIRST TRIMESTER PREGNANCY; HISTOLOGY; MOUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STROMA CELL; UTERUS; VASCULARIZATION;

ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; CELL PROLIFERATION; DECIDUA; EMBRYONIC DEVELOPMENT; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; MALE; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; OVARIECTOMY; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UTERUS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 67651163673     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-1207     Document Type: Article

References (54)

1. Cheng JG, Chen JR, Hernandez L, Alvord WG, Stewart CL 2001 Dual control of LIF expression and LIF receptor function regulate Stat3 activation at the onset of uterine receptivity and embryo implantation. Proc Natl Acad Sci USA 98:8680-8685
2. Lee KY, Jeong JW, Wang J, Ma L, Martin JF, Tsai SY, Lydon JP, DeMayo FJ 2007 Bmp2 is critical for the murine uterine decidual response. Mol Cell Biol 27:5468-5478
3. Chakraborty I, Das SK, Dey SK 1995 Differential expression of vascular endothelial growth factor and its receptor mRNAsin the mouse uterus around the time of implantation. J Endocrinol 147:339-352
4. Goodger AM, Rogers PA 1993 Uterine endothelial cell proliferation before and after embryo implantation in rats. J Reprod Fertil 99:451-457
5. Wang H, Dey SK 2006 Roadmap to embryo implantation: clues from mouse models. Nat Rev Genet 7:185-199
6. Zimmermann RC, Hartman T, Bohlen P, Sauer MV, Kitajewski J 2001 Preovulatory treatment of mice with anti-VEGF receptor 2 antibody inhibits angiogenesis in corpora lutea. Microvasc Res 62:15-25
7. Fraser HM, Wulff C 2003 Angiogenesis in the corpus luteum. Reprod Biol Endocrinol 1:88
8. Rabbani ML, Rogers PA 2001 Role of vascular endothelial growth factor in endometrial vascular events before implantation in rats. Reproduction 122: 85-90
9. Rockwell LC, Pillai S, Olson CE, Koos RD 2002 Inhibition of vascular endothelial growth factor/vascular permeability factor action blocks estrogen-induced uterine edema and implantation in rodents. Biol Reprod 67:1804-1810
10. Walter LM, Rogers PA, Girling JE 2005 The role of progesterone in endometrial angiogenesis in pregnant and ovariectomised mice. Reproduction 129: 765-777
11. Heryanto B, Rogers PA 2002 Regulation of endometrial endothelial cell proliferation by oestrogen and progesterone in the ovariectomized mouse. Reproduction 123:107-113
12. Sengupta J, Lalitkumar PG, Najwa AR, Charnock-Jones DS, Evans AL, Sharkey AM, Smith SK, Ghosh D 2007 Immunoneutralization of vascular endothelial growth factor inhibits pregnancy establishment in the rhesus monkey (Macaca mulatta). Reproduction 133:1199-1211
13. Yeh J, Kim BS, Peresie J 2008 Ovarian vascular endothelial growth factor and vascular endothelial growth factor receptor patterns in reproductive aging. Fertil Steril 89(5 Suppl):1546-1556
14. Douglas NC, Nakhuda GS, Sauer MV, Zimmermann RC 2005 Angiogenesis and ovarian function. J Fertil Reprod 13:7-15
15. Wulff C, Wilson H, Rudge JS, Wiegand SJ, Lunn SF, Fraser HM 2001 Luteal angiogenesis: prevention and intervention by treatment with vascular endothelial growth factor trap(A40). J Clin Endocrinol Metab 86:3377-3386
16. Pauli SA, Tang H, Wang J, Bohlen P, Posser R, Hartman T, Sauer MV, Kitajewski J, Zimmermann RC 2005 The vascular endothelial growth factor (VEGF)/VEGF receptor 2 pathway is critical for blood vessel survival in corpora lutea of pregnancy in the rodent. Endocrinology 146:1301-1311
17. Wulff C, Wilson H, Wiegand SJ, Rudge JS, Fraser HM 2002 Prevention of thecal angiogenesis, antral follicular growth, and ovulation in the primate by treatment with vascular endothelial growth factor Trap R1R2. Endocrinology 143:2797-2807
18. Kashiwagi A, DiGirolamo CM, Kanda Y, Niikura Y, Esmon CT, Hansen TR, Shioda T, Pru JK 2007 The postimplantation embryo differentially regulates endometrial gene expression and decidualization. Endocrinology 148:4173-4184
19. Zimmermann RC, Hartman T, Kavic S, Pauli SA, Bohlen P, Sauer MV, Kitajewski J 2003 Vascular endothelial growth factor receptor 2-mediated angiogenesis is essential for gonadotropin-dependent follicle development. J Clin Invest 112:659-669
20. Donoghue JF, Lederman FL, Susil BJ, Rogers PA 2007 Lymphangiogenesis of normal endometrium and endometrial adenocarcinoma. Hum Reprod 22:1705-1713
21. Vuorela P, Carpén O, Tulppala M, Halmesmäki E 2000 VEGF, its receptors and the tie receptors in recurrent miscarriage. Mol Hum Reprod 6:276-282
22. Wu Y, Zhong Z, Huber J, Bassi R, Finnerty B, Corcoran E, Li H, Navarro E, Balderes P, Jimenez X, Koo H, Mangalampalli VR, Ludwig DL, Tonra JR, Hicklin DJ 2006 Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer. Clin Cancer Res 12:6573-6584
23. Laakkonen P, Waltari M, Holopainen T, Takahashi T, Pytowski B, Steiner P, Hicklin D, Persaud K, Tonra JR, Witte L, Alitalo K 2007 Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth. Cancer Res 67:593-599
24. Tammela T, Zarkada G, Wallgard E, Murtomäki A, Suchting S, Wirzenius M, Waltari M, Hellström M, Schomber T, Peltonen R, Freitas C, Duarte A, Isoniemi H, Laakkonen P, Christofori G, Ylä-Herttuala S, Shibuya M, Pytowski B, Eichmann A, Betsholtz C, Alitalo K 2008 Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 454:656-660
25. Pytowski B, Goldman J, Persaud K, Wu Y, Witte L, Hicklin DJ, Skobe M, Boardman KC, Swartz MA 2005 Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. J Natl Cancer Inst 97:14-21
26. Goldman J, Rutkowski JM, Shields JD, Pasquier MC, Cui Y, Schmökel HG, Willey S, Hicklin DJ, Pytowski B, Swartz MA 2007 Cooperative and redundant roles of VEGFR-2 and VEGFR-3 signaling in adult lymphangiogenesis. Faseb J 21:1003-1012
27. Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, Nagy JA, Hooper A, Priller J, De Klerck B, Compernolle V, Daci E, Bohlen P, Dewerchin M, Herbert JM, Fava R, Matthys P, Carmeliet G, Collen D, Dvorak HF, Hicklin DJ, Carmeliet P 2002 Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 8:831-840
28. Prewett M, Huber J, Li Y, Santiago A, O'Connor W, King K, Overholser J, Hooper A, Pytowski B, Witte L, Bohlen P, Hicklin DJ 1999 Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res 59:5209-5218
29. Wang ES, Teruya-Feldstein J, Wu Y, Zhu Z, Hicklin DJ, Moore MA 2004 Targeting autocrine and paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivo. Blood 104:2893-2902
30. Hattori K, Heissig B, Wu Y, Dias S, Tejada R, Ferris B, Hicklin DJ, Zhu Z, Bohlen P, Witte L, Hendrikx J, Hackett NR, Crystal RG, Moore MA, Werb Z, Lyden D, Rafii S 2002 Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat Med 8:841-849
31. Dumont DJ, Fong GH, Puri MC, Gradwohl G, Alitalo K, Breitman ML 1995 Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev Dyn 203:80-92
32. Dumont DJ, Jussila L, Taipale J, Lymboussaki A, Mustonen T, Pajusola K, Breitman M, Alitalo K 1998 Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282:946-949
33. Ferrara N 2004 Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25:581-611
34. Fong GH, Rossant J, Gertsenstein M, Breitman ML 1995 Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376:66-70
35. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC 1995 Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66
36. Matsumoto H, Ma WG, Daikoku T, Zhao X, Paria BC, Das SK, Trzaskos JM, Dey SK 2002 Cyclooxygenase-2 differentially directs uterine angiogenesis during implantation in mice. J Biol Chem 277:29260-29267
37. Huet-Hudson YM, Andrews GK, Dey SK 1989 Cell type-specific localization of c-myc protein in the mouse uterus: modulation by steroid hormones and analysis of the peri-implantation period. Endocrinology 125:1683-1690
38. Ogle TF 2002 Progesterone-action in the decidual mesometrium of pregnancy. Steroids 67:1-14
39. Halder JB, Zhao X, Soker S, Paria BC, Klagsbrun M, Das SK, Dey SK 2000 Differential expression of VEGF isoforms and VEGF(164)-specific receptor neuropilin-1 in the mouse uterus suggests a role for VEGF(164) in vascular permeability and angiogenesis during implantation. Genesis 26:213-224
40. Pringle KG, Roberts CT 2007 New light on early postimplantation pregnancy in the mouse: roles for insulin-like growth factor-II (IGF-II)? Placenta 28:286-297
41. Girling JE, Lederman FL, Walter LM, Rogers PA 2007 Progesterone, but not estrogen, stimulates vessel maturation in the mouse endometrium. Endocrinology 148:5433-5441
42. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, Wu Y, Hicklin D, Zhu Z, Hackett NR, Crystal RG, Moore MA, Hajjar KA, Manova K, Benezra R, Rafii S 2001 Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 7:1194-1201
43. Kayisli UA, Luk J, Guzeloglu-Kayisli O, Seval Y, Demir R, Arici A 2004 Regulation of angiogenic activity of human endometrial endothelial cells in culture by ovarian steroids. J Clin Endocrinol Metab 89:5794-5802
44. Ma W, Tan J, Matsumoto H, Robert B, Abrahamson DR, Das SK, Dey SK 2001 Adult tissue angiogenesis: evidence for negative regulation by estrogen in the uterus. Mol Endocrinol 15:1983-1992
45. Yoshie M, Tamura K, Hara T, Kogo H 2006 Expression of stathmin family genes in the murine uterus during early pregnancy. Mol Reprod Dev 73:164-172
46. Girling JE, Rogers PA 2005 Recent advances in endometrial angiogenesis research. Angiogenesis 8:89-99
47. Heryanto B, Girling JE, Rogers PA 2004 Intravascular neutrophils partially mediate the endometrial endothelial cell proliferative response to oestrogen in ovariectomised mice. Reproduction 127:613-620
48. Hunt JS, Manning LS, Mitchell D, Selanders JR, Wood GW 1985 Localization and characterization of macrophages in murine uterus. J Leukoc Biol 38:255-265
49. Taylor HS 2004 Endometrial cells derived from donor stem cells in bone marrow transplant recipients. JAMA 292:81-85
50. Plaks V, Birnberg T, Berkutzki T, Sela S, Ben Yashar A, Kalchenko V, Mor G, Keshet E, Dekel N, Neeman M, Jung S 2008 Uterine DCsare crucial for decidua formation during embryo implantation in mice. J Clin Invest 118:3954-3965
51. Vailhé B, Dietl J, Kapp M, Toth B, Arck P 1999 Increased blood vessel density in decidua parietalis is associated with spontaneoushumanfirst trimester abortion. Hum Reprod 14:1628-1634
52. Alvarez C, Alonso-Muriel I, García G, Crespo J, Bellver J, Simón C, Pellicer A 2007 Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: a pilot study. Hum Reprod 22:3210-3214
53. Nathirojanakun P, Taneepanichskul S, Sappakitkumjorn N 2006 Efficacy of a selective COX-2 inhibitor for controlling irregular uterine bleeding in DMPA users. Contraception 73:584-587
54. Cheng CW, Bielby H, Licence D, Smith SK, Print CG, Charnock-Jones DS 2007 Quantitative cellular and molecular analysis of the effect of progesterone withdrawal in a murine model of decidualization. Biol Reprod 76:871-883